News and Comments

PROSENSA: BACK INTO THE LIMELIGHT

  Tuesday, March 18, 2014

Prosensa Holding N.V. (RNA) might have good news that was made possible through insightful observation following past results that almost condemned the Dutch biopharmaceutical company’s compound drisapersen for the treatment of Duchenne Muscular Dystrophy (DMD).  More...


Recent Postings


Archive


Tags

Ocular Therapeutix (OCUL) Aimmune Therapeutics (AIMT) Herceptin Sangamo (SGMO) Seattle Genetics (SGEN) KITE (KITE) Onyx (ONXX) Galena (GALE) Dynavax (DVAX) Bellicum (BLCM) Xoma (XOMA) Sequenom (SQNM) NEKTAR (NKTR)) Multiple Myeloma Alnylam (ALNY) HALOZYME (HALO) Human Longevity (HLI) Incyte (INCY) MODERNA CEMPRA (CEMP) Revlimid (lenolidamide) C4 Therapeutics Rapamune Mirati Therapeutics (MRTX) ImmunoGen (IMGN) Benlysta (belimumab) Velcade (bortezomib) Anacor (ANAC) Dendreon (DNDN) Ariad (ARIA) Illumina (ILMN) Abbott Laboratories (ABT) Amgen (AMGN) PTC Therapeutics (PTCT) Roche (RHHBY) GUARDIAN HEALTH GlaxoSmithKline (GSK) Human Genome Sciences (HGSI) INNOVIVA (INVA) Intercept (ICPT) CompuGen (CGEN) Theravance Bio Pharma (TBPH) Adaptimmune (ADAP) Ionis (IONS) Ziofpharm (ZIOP) Telaprevir VANDA (VNDA) ZALTRAP™ Theravance (THRX) KERYX (KERX) Agenus (AGEN) Prosensa (RNA) AGOS (ARGS) galapagos (GLPG) Intrexon (XON) Zerenex Intermune (ITMN) Biogen Idec (BIIB) Ridaforolimus ISIS (ISIS) BIOMARIN (BMRN) RenenxBio (RGNX) Inovio (INO) Merck (MRK) Genentech OSI (OSIP) Roche (ROCHE) TOKAI (TKAOI) Anadys (ANDS) Vertex (VRTX) Auspex (ASPX) Endometrial Cancer Vitae Pharmaceuticals (VTAE) Prolor Biotech (PBTH) Biocryst (BCRX) NANTKWEST (NK) Advaxis (ADXS) Spike Therapeutics (ONCE) Exelixis (EXEL) JUNO (JUNO) Micromet (MITI) AERIE PHARMACEUTICALS Tysabri Sanofi-Aventis (SAN) ARGOS (ARGS) CRISPR Therapeutics (CRSP) Alder Biopharmaceuticals (ALDR) SYNTA (SNTA) SUNESIS PHARMACEUTICALS (SNSS) Bristol-Myers Squibb (BMY) Array Pharmaceuticals (ARRY) NOVOCURE (NVCR) Valeant Pharmaceuticals International (VRX) ABBVIE (ABBV) Gilead (GILD) Regeneron (REGN) IDERA (IDRA) Elan (ELN) ACADIA (ACAD) Trastuzumab-DM1 Sanofi (SNA) Pluristem (PSTI) ADVENTRIX (ANX) ARCA (ABIO) Jazz Pharmaceuticals (JAZZ) Sarepta (SRPT) Cytokinetics (CYTK) Idenix (IDIX) AstraZeneca (AZN) SERES THERAPEUTICS (MCRB) REGULUS (RGLS) Agenus (AGEN Global Cell Therapeutics (GBT) Sanofi (SNY) Editas (EDIT)